Intrexon to Present at the Stifel 2017 Healthcare Conference

GERMANTOWN, Md., Nov. 10, 2017 /PRNewswire/ -- Intrexon Corporation (NYSE: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today announced that Randal J. Kirk, Chairman and Chief Executive Officer of Intrexon, will present at the Stifel 2017 Healthcare Conference at the Lotte New York Palace Hotel in New York on Tuesday, November 14th at 10:15 a.m. Eastern Time.

A live webcast of the presentation will be available on the Investors section of Intrexon's website at http://investors.dna.com/events.  A replay of the webcast will be available for 30 days following the event.

About Intrexon CorporationIntrexon Corporation (NYSE: XON) is Powering the Bioindustrial Revolution with Better DNA™ to create biologically-based products that improve the quality of life and the health of the planet.  Intrexon's integrated technology suite provides its partners across diverse markets with industrial-scale design and development of complex biological systems delivering unprecedented control, quality, function, and performance of living cells.  We call our synthetic biology approach Better DNA®, and we invite you to discover more at www.dna.com or follow us on Twitter at @Intrexon, on Facebook, and LinkedIn.

TrademarksIntrexon, Powering the Bioindustrial Revolution with Better DNA, and Better DNA are trademarks of Intrexon and/or its affiliates. Other names may be trademarks of their respective owners.

Safe Harbor StatementSome of the statements made in this press release are forward-looking statements.  These forward-looking statements are based upon our current expectations and projections about future events and generally relate to our plans, objectives and expectations for the development of our business.  Although management believes that the plans and objectives reflected in or suggested by these forward-looking statements are reasonable, all forward-looking statements involve risks and uncertainties and actual future results may be materially different from the plans, objectives and expectations expressed in this press release.

For more information regarding Intrexon Corporation, contact:

Investor Contact:Christopher BastaVice President, Investor RelationsTel: +1 (561) 410-7052[email protected]

Corporate Contact:Marie Rossi, Ph.D. Senior Manager, Technical CommunicationsTel: +1 (301) 556-9850[email protected]

View original content with multimedia:http://www.prnewswire.com/news-releases/intrexon-to-present-at-the-stifel-2017-healthcare-conference-300553805.html

SOURCE Intrexon Corporation